References
- Corapcioglu F, Sarialioglu F, Olgun N, Uysal KM. Analysis of 136 febrile neutropenic episodes in children with cancer: Evaluation of treatment effectiveness and cost. Pediatr Hematol Oncol 2004;21:533-41 https://doi.org/10.1080/08880010490477347
- Ramphal R. Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilites of the currently isolated pathogens. Clin Infect Dis 2004;39:S25-31 https://doi.org/10.1086/383048
- Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103-10 https://doi.org/10.1086/374339
- Lai HP, Hsueh PR, Chen YC, Lee PI, Lu CY, Lu MY, et al. Bacteremia in hematological and oncological children with febrile neutropenia: experience in a tertiary medical center in Taiwan. J Microbiol Immunol Infect 2003;36:197- 202
- Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996;15:291-6 https://doi.org/10.1007/BF01695660
- Kim YH, Lee HD, Hah JO. Bacteremia in pediatric cancer patients : Causative organisms and antibiotic sensitivities. Korean J Pediatr 2005;48:619-23
- Wang FD, Lin ML, Liu CY. Bacteremia in patients with hematological malignancies. Chemotherapy 2005;51:147-53 https://doi.org/10.1159/000085623
- Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51 https://doi.org/10.1086/339215
- Lee SL, Kim JS, Kim HS, Kang CM. A study on infection in childhood acute leukemia. Korean J Infect Dis 1990;22: 33-41
- Oppenheim BA. The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 1998;41:S7-11 https://doi.org/10.1093/jac/41.suppl_4.7
- Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteremia : report of four cases and review of the literature. Clin Infect Dis 1996;23:569-76 https://doi.org/10.1093/clinids/23.3.569
- Oie S, Kamiya A. Microbial contamination of antisepticsoaked cotton balls. Biol Pharm Bull 1997;20:667-9 https://doi.org/10.1248/bpb.20.667
- Aisenberg G, Rolston KV, Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer(1989-2003). Cancer 2004;101:2134-40 https://doi.org/10.1002/cncr.20604
- Gomez-Cerezo J, Suarez I, Rios JJ, Pena P, Garcia de Miguel MJ, de Jose M, et al. Achromobacter xylosoxidans bacteremia : a 10-year analysis of 54 cases. Eur J Clin Microbiol Infect Dis 2003;22:360-3 https://doi.org/10.1007/s10096-003-0925-3
- Martino R, Martinez C, Pericas R, Salazar R, Sola C, Brunet S, et al. Bacteremia due to glucose non-fermenting Gram-negative bacilli in patients with hematological neoplasias and solid tumors. Eur J Clin Microbiol Infect Dis 1996:610-5
- Tsay RW, Lin LC, Chiou CS, Liao JC, Chen CH, Liu CE, et al. Alcaligenes xylosoxidans bacteremia : clinical features and microbiological characteristics of isolates. J Microbiol Immunol Infect 2005:194-9
- Zaoutis TE, Goyal M, Chu JH, Coffin SE, Bell LM, Nachamkin I, et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase- producing Escherichia coli and Klebsiella species in children. Pediatrics 2005;115:942-9 https://doi.org/10.1542/peds.2004-1289
-
Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum
${\beta}$ -lactamases : implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206-12 https://doi.org/10.1128/JCM.39.6.2206-2212.2001 - Schiappa DA, Hayden MK, Matushek MG, Hashemi FN, Sullivan J, Smith KY, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection : a case-control and molecular epidemiologic investigation. J Infect Dis 1996;174:529-36 https://doi.org/10.1093/infdis/174.3.529
-
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum
${\beta}$ -lactamase-producing Escherichia coli and Klebsiella pneumoniae : risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-71 https://doi.org/10.1086/319757 - Nordmann P, Poirel L. Emerging carbapenemases in gramnegative aerobes. Clin Microbiol Infect 2002;8:321-31 https://doi.org/10.1046/j.1469-0691.2002.00401.x
-
Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections due to extended-spectrum
${\beta}$ - lactamase-producing Escherichia coli and Klebsiella pneumoniae : risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004;48:4574-81 https://doi.org/10.1128/AAC.48.12.4574-4581.2004 - Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-7 https://doi.org/10.1056/NEJMoa025025
- Kacica M, McDonald LC. Brief report : vancomycin-resistant Staphylococcus aureus-New York, 2004. MMWR 2004; 53:322-3
- Tenover FC, Weigel LM, Appelbaum PC, McDougal LK, Chaitram J, McAllister S, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004;48:275-80 https://doi.org/10.1128/AAC.48.1.275-280.2004
- Streit JM, Jones RN, Sader HS, Fritsche TR. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit : report from the SENTRY antimicrobial surveillance program(North America, 2001). Int J Antimicrob Agents 2004;24:111-8 https://doi.org/10.1016/j.ijantimicag.2003.12.019
- Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Ann Clin Microbiol Antimicob 2004;3:7 https://doi.org/10.1186/1476-0711-3-7
- Gilrane T, Tracy JD, Greenlee RM, Schelpert JW 3rd, Brandstetter RD. Neisseria sicca pneumonia. Report of two cases and revieww of the literature. Am J Med 1985;78: 1038-40 https://doi.org/10.1016/0002-9343(85)90230-X
- Chao HC, Chiu CH, Huang YC, Lin TY, Su WJ. Endocarditis due to Neisseria sicca: report of one case. Chung-Hua Min Kuo Hsiao Ko I Hsueh Hui Tsa Chih 1997;38: 229-31
- Berman MM, Gagnon D, Doern GV. Pichia ohmeri fungemia. Diagn Microbiol Infect Dis 1998;30:229-31 https://doi.org/10.1016/S0732-8893(97)00233-2
- Otag F, Kuyucu N, Erturan Z, Sen S, Emekdas G, Sugita T. Outbreak of Pichia ohmeri infection in the paediatric intensive care unit : case reports and review of the literature. Mycoses 2005;48;265-9 https://doi.org/10.1111/j.1439-0507.2005.01126.x
- Riquelme AJ, Calvo MA, Guzman AM, Depix MS, Garcia P, Perez C, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol 2003;36:41-3 https://doi.org/10.1097/00004836-200301000-00013
- Lherm T, Monet C, Nougiere B, Soulier M, Larbi D, Le Gall C, et al. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002; 28:797-801 https://doi.org/10.1007/s00134-002-1267-9
- Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000;8:504-5 https://doi.org/10.1007/s005200000123
- Fiore NF, Conway JH, West KW, Kleiman MB. Saccharomyces cerevisiae infections in children. Pediatr Infect Dis J 1998;17:1177-9 https://doi.org/10.1097/00006454-199812000-00022